These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2505011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain.
    Schriefer A, Maltez JR, Silva N, Stoeckle MY, Barral-Netto M, Riley LW.
    Vaccine; 1999 Feb 26; 17(7-8):770-8. PubMed ID: 10067682
    [Abstract] [Full Text] [Related]

  • 3. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine.
    Delvig AA, Wedege E, Caugant DA, Dalseg R, Kolberg J, Achtman M, Rosenqvist E.
    Microbiology (Reading); 1995 Jul 26; 141 ( Pt 7)():1593-600. PubMed ID: 7551027
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
    Tappero JW, Lagos R, Ballesteros AM, Plikaytis B, Williams D, Dykes J, Gheesling LL, Carlone GM, Høiby EA, Holst J, Nøkleby H, Rosenqvist E, Sierra G, Campa C, Sotolongo F, Vega J, Garcia J, Herrera P, Poolman JT, Perkins BA.
    JAMA; 1999 Apr 28; 281(16):1520-7. PubMed ID: 10227322
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M, Yero D, Niebla O, González S, Climent Y, Pérez Y, Cobas K, Caballero E, García D, Pajón R.
    Vaccine; 2007 Dec 05; 25(50):8420-31. PubMed ID: 17996338
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
    van der Voort ER, van der Ley P, van der Biezen J, George S, Tunnela O, van Dijken H, Kuipers B, Poolman J.
    Infect Immun; 1996 Jul 05; 64(7):2745-51. PubMed ID: 8698504
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
    Rosenqvist E, Musacchio A, Aase A, Høiby EA, Namork E, Kolberg J, Wedege E, Delvig A, Dalseg R, Michaelsen TE, Tommassen J.
    Infect Immun; 1999 Mar 05; 67(3):1267-76. PubMed ID: 10024570
    [Abstract] [Full Text] [Related]

  • 11. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
    Pillai S, Howell A, Alexander K, Bentley BE, Jiang HQ, Ambrose K, Zhu D, Zlotnick G.
    Vaccine; 2005 Mar 18; 23(17-18):2206-9. PubMed ID: 15755596
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and Y.
    Bisaillon JG, McSween G, Portelance V, Beaudet R, Morosoli R, Pouliot P, Micusan V.
    Microbios; 1989 Mar 18; 60(244-245):193-208. PubMed ID: 2515422
    [Abstract] [Full Text] [Related]

  • 14. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
    Moe GR, Zuno-Mitchell P, Lee SS, Lucas AH, Granoff DM.
    Infect Immun; 2001 Jun 18; 69(6):3762-71. PubMed ID: 11349041
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.
    Martin D, Cadieux N, Hamel J, Brodeur BR.
    J Exp Med; 1997 Apr 07; 185(7):1173-83. PubMed ID: 9104804
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
    Pajon R, Buckwalter CM, Johswich KO, Gray-Owen SD, Granoff DM.
    Vaccine; 2015 Mar 10; 33(11):1317-1323. PubMed ID: 25662856
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.